Ignite Creation Date:
2025-12-25 @ 3:32 AM
Ignite Modification Date:
2026-01-09 @ 9:34 PM
Study NCT ID:
NCT01871805
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2013-05-28
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-30
Start Date Type:
ACTUAL
Primary Completion Date:
2014-10-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-28
First Submit QC Date:
None
Study First Post Date:
2013-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-14
Results First Submit QC Date:
None
Results First Post Date:
2016-02-12
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-23
Last Update Post Date:
2018-08-21
Last Update Post Date Type:
ACTUAL